Sub menu

Vaccines

Comirnaty Original ([Pfizer] 5 - <12 years formulation [orange cap])

Details for Comirnaty Original ([Pfizer] 5 - <12 years formulation [orange cap]) vaccine and its components.

Recently added

This page was added on 05 October 2023.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
Pfizer Australia
Administration route
Intramuscular injection
Vaccine group
Paediatric formulations
Description:

5 – <12 years formulation

COVID-19 vaccine containing nucleoside-modified mRNA encoding the spike glycoprotein of SARS-CoV-2 Wuhan-Hu-1 strain.

Tris/sucrose presentation. Multidose vial containing 10 doses in 1.3 mL. Requires dilution with 1.3 mL of sterile 0.9% NaCl without preservative into each multidose vial.

Each 0.2 mL dose contains:

  • 10 µg mRNA 
  • ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315)
  • 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159)
  • distearoylphosphatidylcholine (DSPC)
  • cholesterol
  • trometamol
  • trometamol hydrochloride
  • sucrose
  • water for injection

For Product Information and Consumer Medicine Information about Comirnaty Original ([Pfizer] 5 - <12 years formulation [orange cap]) visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
COVID-19

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/comirnaty-original-pfizer-5

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.